Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001432456 | SCV001635227 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2023-01-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258253 | SCV002533640 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-26 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002258253 | SCV002743893 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV004789590 | SCV005405852 | benign | Familial cancer of breast | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |